Excitatory synaptic transmission is modulated by inhibitory neurotransmitters and neuromodulators. We found that the synaptic transmission of somatic sensory afferents can be rapidly regulated by a presynaptically secreted protein, follistatin-like 1 (FSTL1), which serves as a direct activator of Na + ,K + -ATPase (NKA). The FSTL1 protein is highly expressed in small-diameter neurons of the dorsal root ganglion (DRG). It is transported to axon terminals via small translucent vesicles and secreted in both spontaneous and depolarization-induced manners. Biochemical assays showed that FSTL1 binds to the a1 subunit of NKA and elevates NKA activity. Extracellular FSTL1 induced membrane hyperpolarization in cultured cells and inhibited afferent synaptic transmission in spinal cord slices by activating NKA. Genetic deletion of FSTL1 in small DRG neurons of mice resulted in enhanced afferent synaptic transmission and sensory hypersensitivity, which could be reduced by intrathecally applied FSTL1 protein. Thus, FSTL1-dependent activation of NKA regulates the threshold of somatic sensation.
INTRODUCTION
The efficacy of synaptic transmission is modulated by the presynaptic actions of neurotransmitters and neuromodulators (Engelman and MacDermott, 2004; Hyman, 2005) , which regulate the presynaptic release of neurotransmitters by binding to specific membrane receptors (Hyman, 2005) . Small-diameter neurons in the dorsal root ganglion (DRG) give rise to unmyelinated axons (C-fibers) and thinly myelinated axons (Ad-fibers) that terminate in laminae I-II of the spinal cord. These axons convey the somatic sensory signals generated by nociceptors, thermoreceptors, and sensitive mechanoreceptors (Maxwell and Rethelyi, 1987; Woolf and Ma, 2007) . In response to peripheral stimulation, these axons release glutamate and neuropeptides, substance P (SP), and calcitonin gene-related peptide (CGRP) via exocytosis of synaptic vesicles and large dense-core vesicles (LDCVs). This excitatory synaptic transmission is modulated by the inhibitory neurotransmitter g-aminobutyric acid and opioid peptides secreted by spinal interneurons. The present study demonstrates a regulatory system that consists of the follistatin-like 1 (FSTL1) protein secreted from afferent axons and its presynaptic receptor, the a1 subunit of Na + ,K + -ATPase (NKA) (Kaplan, 2002) . The glycoprotein FSTL1 was initially discovered when previous investigators found that FSTL1 could be induced by transforming growth factor-b1 (Shibanuma et al., 1993; Zwijsen et al., 1994) . FSTL1 is one of the secreted proteins rich in cysteine (SPARC) that contain one follistatin-like domain and a pair of EF-hands (Grabarek, 2006) . FSTL1 belongs to a subfamily of the follistatin gene family (Brekken and Sage, 2000; Hambrock et al., 2004 ), but does not bind to activin. FSTL1 has been shown to reduce the growth of cancer cells (Mashimo et al., 1997; Sumitomo et al., 2000) , act as an Akt protein kinase-regulated cardioprotective factor in the heart (Oshima et al., 2008) , and serve as a target protein for autoantibodies in human rheumatoid arthritis (Tanaka et al., 1998 (Tanaka et al., , 2003 . However, the receptor for FSTL1 in the body was not identified. Additionally, FSTL1 was found to be expressed in the nervous system (De Groot et al., 2000; Malik-Hall et al., 2003) , but the neuronal function of FSTL1 was unknown. In this study, we found high levels of FSTL1 in small DRG neurons. Surprisingly, unlike neuropeptides and brain-derived neurotrophic factor, which are secreted via LDCVs (Salio et al., 2005) , we observed that FSTL1 is transported to axon terminals via small translucent vesicles and secreted in a manner similar to neurotransmitters.
We further found that FSTL1 directly activates a1 subunit-containing NKA (a1NKA). NKA, also known as an Na + -K + pump, transports three Na + out of cell and two K + into cell, thereby playing a crucial role in maintaining the Na + and K + gradient across the plasma membrane. This gradient is essential for maintaining the resting membrane potential and excitable properties of neurons (Hamada et al., 2003; Kaplan, 2002; Morth et al., 2007; Takeuchi et al., 2008) . NKA activity is regulated by direct modulators (ATP, Na + , K + , and cardiotonic steroid inhibitors ouabain and digoxin) and indirect modulators (catecholamines, insulin, angiotensin II, and morphine) through receptor-mediated mechanisms (Therien and Blostein, 2000) . NKA is a heterodimer composed of one a subunit and one b subunit. The catalytic, transport, and pharmacological properties of NKA reside in the a subunit, while the b subunit is involved in cell surface delivery and appropriate insertion of the a subunit. Four isoforms of a subunits (a1-a4) and three isoforms of b subunits (b1-b3) are expressed in a tissueand cell-dependent pattern. It was unknown whether NKA could be regulated by endogenous agonists.
The mRNAs for NKA a1, a3, and b1 subunits were found in the DRG (Fink et al., 1995; Hamada et al., 2003; Mata et al., 1991) . The a1 subunit is expressed in both small-and large-diameter DRG neurons, whereas the a3 subunit is mainly distributed in large ones (Dobretsov et al., 1999a (Dobretsov et al., , 1999b . Electrophysiology showed that the membrane current produced by NKA activity in DRG neurons was primarily mediated by a1NKA (Hamada et al., 2003; Mata et al., 1991) . Reduction in NKA activity in the peripheral nerve was found to be partly responsible for diabetic neuropathy, which presents sensory symptoms such as paresthesias and pain (Krishnan and Kiernan, 2005; Vague et al., 2004) . We identified FSTL1 as an a1NKA agonist that suppresses synaptic transmission and maintains the normal threshold of somatic sensation. This finding revealed an agonist-dependent mechanism for activating the Na + -K + pump and provided further insight about the pump's physiological role.
RESULTS

FSTL1 Is Highly Expressed in DRG Neurons
In an attempt to identify novel functional molecules in DRG neurons, we searched for genes expressed at high levels in the DRG but at low levels in other tissues. Utilizing two available databases (see Supplemental Experimental Procedures), we found 71 candidate genes and verified their expression patterns with a microarray ( Figure S1 , available online). Fstl1 was one of the genes with the highest expression level in the DRG of adult rats ( Figure S1 and Tables S1-S3 ). Both northern blotting ( Figure 1A ) and immunoblotting ( Figure 1B ) with specific FSTL1 antibodies ( Figure S2A ) confirmed the abundant expression of FSTL1 in the DRG. Low levels of FSTL1 were also present in heart, lung, brain, kidney, and muscle ( Figure S1 ). Immunostaining showed that FSTL1 was enriched in DRG ( Figure 1C ) and trigeminal ganglion ( Figure S2B ) neurons of both rats and mice. In the brain, FSTL1 was found in the mesencephalic trigeminal nucleus, the red nucleus, and the oculomotor nucleus ( Figure S2B ). In rat DRGs, FSTL1 was expressed in $60% of small neurons at high levels and in $10% of large neurons at low levels ( Figure 1C ). Small neurons consist of peptidergic neurons, e.g., those containing CGRP and SP, and nonpeptidergic neurons, which bind isolectin B4 (IB4). Approximately 54% of FSTL1-positive small neurons contained CGRP, while $45% were labeled by IB4 (Figure 1D ). Approximately 89% of CGRP-positive neurons and $55% of IB4-positive neurons expressed FSTL1. The FSTL1-positive neurons contained the vanilloid receptor type 1 (TRPV1) ($56%) and the Na v 1.8 channel ($90%) ( Figure 1D ). In laminae I-II of the spinal cord, FSTL1 was seen in most CGRP-positive afferents ( Figure 1E ) and some IB4-positive ones. However, FSTL1 labeling in axons was weaker than the labeling in the cell body. Weak FSTL1 labeling was also seen in some afferent fibers in laminae III-IV. Thus, FSTL1 is synthesized in the cell body of DRG neurons and transported to their axon terminals.
FSTL1 Is Transported via Small Translucent Vesicles
Synaptic vesicles and LDCVs in axon terminals release their contents in response to stimulus-induced elevation of intracellular Ca 2+ ([Ca 2+ ] i ). Synaptic vesicles are then recycled in axon terminals, while LDCVs have to be generated in the cell body. Double immunostaining showed that FSTL1 was localized in vesicles that contained neither CGRP nor SP ( Figure 1F ) in small DRG neurons. These FSTL1 vesicles were also seen in IB4-positive neurons ( Figure 1F ). Postembedding immunogold labeling showed that FSTL1 was localized to small translucent vesicles (30-80 nm in diameter) near the trans-Golgi network (TGN) and in the afferent axons of dorsal roots ( Figure 2A ). In spinal lamina II, FSTL1 vesicles were observed in the afferent terminals identified as the central terminal of glomeruli and sometimes in the presynaptic active zone (Figure 2A ). Moreover, pre-embedding immunoperoxidase staining also showed the FSTL1-immunoreactive vesicles in the axonal terminals and some of these vesicles near the presynaptic membrane ( Figure 2B ). To confirm the morphological results, we used subcellular fractionation with a sucrose gradient to separate different vesicle populations in the spinal dorsal horn of rats ( Figure 2C ). We found that FSTL1 mainly appeared in small vesicle fractions that contained synaptoporin, a member of the synaptophysin superfamily and an integral membrane component of synaptic vesicles in afferent terminals (Sun et al., 2006) , but not in LDCV fractions labeled by CGRP ( Figure 2C ). Thus, FSTL1 is localized to small translucent vesicles.
The identity of FSTL1 vesicles was further analyzed in the afferent axons of dorsal roots. Double immunostaining showed that $53% of FSTL1 vesicles (n = 2050 in 212 axon profiles) contained vesicular glutamate transporter 2 (VGluT2) in the axons of rats ( Figure 2D ) and mice ( Figure S3A ). Also, $39% of the vesicles contained vesicle-associated membrane protein 2 (VAMP2) (n = 378 in 35 axon profiles) ( Figure 2D ). However, only a small number of FSTL1 vesicles contained synaptoporin ($12%, n = 2624 in 138 axon profiles) or synapsin ($14%, n = 777 in 64 axon profiles) ( Figure 2D ). Thus, newly synthesized FSTL1 is mainly transported via VGluT2-and VAMP2-containing vesicles, while only a small amount of FSTL1 is transported via the vesicles carrying synaptoporin and synapsin (Hannah et al., 1999; Santos et al., 2009 ).
Spontaneous and Depolarization-Induced Secretion of FSTL1
We directly examined the potential secretion of FSTL1 in DRG neurons cultured from young rats. Immunoblot analysis showed that the level of FSTL1 in the culture medium was increased in the absence of the stimulus ( Figure 2E ), indicating spontaneous activator, capsaicin, and that response was abolished by the TRPV1 channel blocker, capsaizepine ( Figure 2F ).
Additionally, high-K + stimulation for 15 min enhanced FSTL1 secretion from the spinal cord slices of rats ( Figure 2H ) and mice ( Figure S3B ) as well as synaptosomes prepared from the spinal dorsal horn ( Figure 2I ). As expected, the secretion of CGRP, SP, and glutamate was also increased in the same preparation ( Figures 2H and 2I ). The stimulus-evoked secretion of FSTL1 from synaptosomes occurred only in the presence of [Ca 2+ ] o ( Figure 2I ). In contrast, the spontaneous secretion of tenascin-C, an extracellular matrix glycoprotein (Joester and Faissner, 2001) , was unaffected by the K + stimulation ( Figure 2I and Figure S3C ). Together, these results suggest that FSTL1 is stored in small translucent vesicles and can be secreted either spontaneously or by depolarization in a manner similar to neurotransmitters.
FSTL1 Inhibits Synaptic Transmission
To determine whether secreted FSTL1 plays a physiological role in the spinal cord, we performed whole-cell recording of lamina II neurons to monitor afferent synaptic transmission in dorsal root-attached spinal cord slices from rats (Nakatsuka et al., 2000) . We transfected the plasmid-expressing rat FSTL1 fused with myc and
His tags into human embryonic kidney (HEK) 293T cells and purified the resulting recombinant FSTL1 protein ( Figure 3A and Figure S3D ). The secreted form of recombinant FSTL1 was glycosylated and had a molecular mass of $37-45 kDa (Figure S3D) . Deglycosylated FSTL1 had a molecular weight of $34 kDa ( Figure S3D ). Recombinant glycosylated FSTL1 was used to examine the effect of exogenous FSTL1 on synaptic transmission between afferent terminals and local neurons in lamina II (substantia gelatinosa), a translucent band in the superficial dorsal horn. We found that among $50% (16/31) of recorded neurons, application of FSTL1 (60 or 300 nM) resulted in a reduction of more than 10% in the mean frequency or mean amplitude of spontaneous excitatory postsynaptic currents (sEPSCs) ( Figure 3B ). Similar application of FSTL1 also reduced the amplitude of C-fiber stimulation evoked EPSCs (eEPSCs), which were present in 50% (12/24) of recorded monosynaptic neurons ( Figures 3C and 3D) . A similar inhibitory effect of FSTL1 (60 nM) was found in polysynaptic neurons ( Figure S3E ). Further studies of miniature EPSCs (mEPSCs) in the presence of tetrodotoxin (0.5 mM) showed that FSTL1 also reduced the frequency, but not the amplitude, of mEPSCs ( Figure 3E ), suggesting that there is presynaptic suppression of glutamate release by FSTL1. The decay kinetics of eEPSCs were unaffected by FSTL1 ( Figure 3D ), indicating that FSTL1 had no direct effect on postsynaptic glutamate receptor channel properties. Together, these results suggest that FSTL1 acts presynaptically on neurotransmitter release, rather than postsynaptically on glutamate responses. In addition, for neurons that showed FSTL1-induced eEPSC reduction, the synaptic delay after C-fiber stimulation was reversibly increased ( Figure 3C ), suggesting a presynaptic reduction of excitation-secretion coupling and/or impeded action potential (AP) propagation in the C-fiber.
Finally, the specificity of FSTL1 function was indicated by the lack of synaptic suppression effects of follistatin or two mutated forms of FSTL1 that either have a pair of EF-hands deleted (FSTL1 DEF ) or a loss-of-function mutation at the Ca 2+ -binding site Glu 165 (FSTL1 E165A ), which is conserved across species (Figures 3C and 3E and Figures S3F and S3G) . Thus, exogenous FSTL1 suppresses afferent synaptic transmission in the dorsal horn through presynaptic inhibition. His tags to components present on the surface of cultured rat DRG neurons. The cell lysate was analyzed by an immunoblot with myc antibodies. An immunoreactive band with a molecular weight of $140 kDa, which is much larger than the expected mass of recombinant FSTL1 ($37-45 kDa, depending on the glycosylation status), appeared when cells were crosslinked with FSTL1 ( Figure 4A ), suggesting that FSTL1 associates with a membrane protein that has a molecular weight of $100 kDa. The crosslinked proteins were purified and analyzed by mass spectrometry (MS). In addition to the peptide sequences of FSTL1, 3-7 peptides matched the a1 subunit of NKA. The data from three samples represented 15% coverage of the a1 subunit sequence. This result was confirmed by an immunoblot of DRG cell lysates with a1 subunit antibodies that showed the crosslinked protein at $140 kDa, in addition to the predicted a1 subunit ($100 kDa, Figure 4B ) (Nishi et al., 1999) . In contrast, immunoblotting for the a3 subunit ($110 kDa) (Nishi et al., 1999) in the same lysate showed no crosslinked proteins at higher molecular weights ( Figure 4B ), indicating a specific FSTL1 interaction with the a1, but not the a3 subunit (Dobretsov et al., 1999b; Hamada et al., 2003) .
FSTL1 Binds to the
In situ hybridization ( Figure S4A ) and immunostaining (Figure 4C) showed that the a1 subunit was expressed in $51% of rodent DRG neurons. Of the neurons, $63% were small neurons and FSTL1 was also expressed in $66% of a1 subunit-containing neurons ( Figure 4C ). Coimmunoprecipitation (co-IP) studies showed an interaction between the NKA a1 subunit and FSTL1 in rat DRG extracts ( Figure 4D ). Furthermore, we cotransfected the plasmids expressing the a1 subunit and FSTL1 or its mutant into COS7 cells in which FSTL1 was absent and the endogenous a1 subunit was expressed at a low level ($8% of the expression in DRG) ( Figure S4B ). We found that the a1 subunit interacted with FSTL1 ( Figure 4E ), but not with the loss-of-function mutant FSTL1
E165A and FSTL1 DEF ( Figures S4C and S4D ). Furthermore, an equilibrium binding assay showed that 125 I-FSTL1 exhibited dose-dependent binding to COS7 cells expressing exogenous a1 and b1 subunits ( Figure 4F ). The assay yielded an apparent dissociation constant (K D ) of $43 nM, indicating the presence of high-affinity binding. Consistent with the requirement of both a1 and b1 subunits for functional assembly of NKA and the involvement of the b subunit in cell surface delivery and appropriate insertion of the a subunit (Kaplan, 2002) , we found that 125 I-FSTL1 did not bind to cells expressing only the a1 or b1 subunit (data not shown). 125 I-FSTL1 also did not specifically bind to the cells expressing a3 and b1 subunits ( Figure 4F ) or the cells transfected with the pIRES-EGFP plasmid (data not shown). Together, these results indicate that FSTL1 directly binds to the a1 subunit of NKA.
Identification of Interaction Domains in the a1 Subunit
The a subunit has ten transmembrane segments (M1-M10) and five extracellular loops (ELs M1M2, M3M4, M5M6, M7M8, and M9M10), while both termini are intracellular (Kaplan, 2002; Morth et al., 2007) . To search the FSTL1-binding domain in the a1 subunit, we synthesized peptides corresponding to each of the five predicted extracellular loops and then performed the BIAcore analysis. We observed the binding of FSTL1 to the M3M4 peptide (equilibrium K D : $258 mM) and the M7M8 peptide (K D : $53 mM) ( Figure 4G ), while the M1M2 peptide had a low-binding affinity (K D : $72 mM). There was no detectable binding for M5M6 and M9M10 peptides. Thus, the M3M4 and M7M8 ELs might be involved in the interaction with FSTL1 ( Figure 4G ). We then determined the binding sites in transfected COS7 cells by examining the interaction between FSTL1 and a FLAG-tagged a1 subunit with a point mutation at various sites in the M3M4 or M7M8 loops that differ from the a3 subunit. We found that This effect was attenuated by capsaizepine (CPZ; 10 mM) (**p < 0.01 versus control; ## p < 0.01, n = 3). Data shown are mean ± SEM.
Neuron FSTL1 Activates Presynaptic Na + -K + Pump effect on the co-IP signal of FSTL1 with the FLAG-tagged a1 subunit ( Figure S4E ). Furthermore, a significant co-IP signal was observed when we expressed a FLAG-tagged a3 subunit containing a Glu substitution of Gly 304 and Thr substitution of Asn 879 ( Figure 4H ). Thus, Glu 314 and Thr 889 in the NKA a1 subunit are critical for FSTL1-binding ( Figure 4I ).
FSTL1 Activates NKA
The functional consequence of FSTL1 binding to the a1 subunit was directly shown by the dose-dependent activation of the NKA enzyme with recombinant FSTL1 in cultured DRG neurons (EC 50 = 28.6 nM, Figure 5A ). Consistent with a1-specific binding between FSTL1 and NKA, we found that the NKA activity was dose dependently elevated by FSTL1 in COS7 cells expressing a1 and b1 subunits (EC 50 = 28.0 nM, Figure 5A ), but not in cells expressing a3 and b1 subunits, a1 E314G and b1 subunits, or a1 T889N and b1 subunits ( Figures 5A and 5B) . The loss-of-function mutant FSTL1 E165A and FSTL1 DEF had no effect on the NKA activity of COS7 cells expressing a1 and b1 subunits (Figure 5B ). The effect of FSTL1 was further analyzed with the NKA (G) The K + -induced secretion of FSTL1 was attenuated when extracellular Ca 2+ ([Ca 2+ ] o ) was absent, whereas the basal secretion of FSTL1 was unaffected (*p < 0.05 versus control; #p < 0.05, n = 4). Data shown are mean ± SEM. (H, I) Treatment with KCl (55 mM, 15 min) elevated the FSTL1 level in the buffer incubating the rat spinal cord slice (n = 3) (H) or the synaptosomes isolated from the spinal dorsal horn (n = 4) (I) in the presence of extracellular Ca 2+ ([Ca 2+ ] o ). (I) The K + -enhanced secretion of CGRP, SP, and glutamate (Glu) from the synaptosomes was found with the immunoassay, the radioimmunoassay, and the HPLC methods, respectively. However, high K + did not increase the secretion of tenascin-C (*p < 0.05; **p < 0.01; ***p < 0.001 versus control). Data shown are mean ± SEM. Neuron FSTL1 Activates Presynaptic Na + -K + Pump partially purified from the dorsal spinal cord of rats. The NKA activity was apparently increased 1 min after the treatment with FSTL1 (60 nM) and reached a peak level at 3 min ( Figure 5C ). Consistent with the enzymatic activity assay, whole-cell recording showed that bath-applied FSTL1 induced hyperpolarization (6.8 ± 1.7 mV, n = 12) of COS7 cells expressing a1 and b1 subunits, but not cells expressing a3 and b1 subunits (0.6 ± 0.4 mV, n = 8) ( Figure 5D ).
Furthermore, the M3M4 or M7M8 peptides could serve as blockers for FSTL1 interaction with a1NKA, as shown by our findings that the binding of 125 I-FSTL1 to a1 and b1 subunitexpressing COS7 cells was attenuated by either the M3M4 (EC 50 = 3.6 mM) or the M7M8 peptide (EC 50 = 2.9 mM) ( Figure 5E ), but not by other EL peptides ( Figure 5E and Figure S4F ). The FSTL1-induced elevation of NKA enzyme activity was similarly blocked by these two peptides ( Figure 5F ). Taken together, these -FLAG. FSTL1-myc did not interact with a3 subunit-FLAG but interacted with a3 subunit G304E, N879T -FLAG. The immunoblots shown are representatives of three such experiments. (I) The localization of E314 and T889 was mapped onto a homology model of the a1 subunit based on the PDB 3B8E structure (Morth et al., 2007) , viewed from the extracellular surface (top) and the membrane plane.
Neuron FSTL1 Activates Presynaptic Na + -K + Pump findings suggest that FSTL1 activates NKA via direct binding to the a1 subunit. The consequence of FSTL1-induced NKA activation was further demonstrated in cultured small DRG neurons (15-25 mm in diameter) by FSTL1-induced membrane hyperpolarization (7.6 ± 0.6 mV, n = 7), reduced frequency of APs initiated by depolarizing currents (Figure 5G ), and prolonged afterhyperpolarization ( Figure S4G ), which typically reduces AP firing (Pulver and Griffith, 2010; Sah, 1996; Zhang et al., 2010) . FSTL1 E165A did not induce such effects ( Figure S4H ). The FSTL1 actions were abolished by ouabain, an NKA inhibitor (Kaplan, 2002) (G) Current-clamp recording in small neurons dissociated from rat DRGs showed that FSTL1 (30 nM) reduced the AP frequency triggered by current injection and induced membrane hyperpolarization. Both effects were abolished by coapplied ouabain (OB, 100 mM, n = 7) or M3M4 peptide (10 mM, n = 6). Red lines indicate À60 mV.
which binds to the M4 and the M5-M6 hairpin of the a1 subunit (Qiu et al., 2005) at a concentration of 100 mM (Figure 5G ), but not at 1 mM (data not shown). This effect is consistent with the lower ouabain sensitivity of a1NKA (Dobretsov et al., 1999a; Hamada et al., 2003) . FSTL1 actions were also antagonized by the presence of the M3M4 ( Figure 5G ), but not the M9M10 peptide (data not shown). Thus, FSTL1-induced a1NKA activation regulates both membrane potential and neuronal excitability.
FSTL1 Regulates Synaptic Transmission by Activating NKA
The a1 subunit immunostaining was present in laminae I-IV of the rodent spinal cord ( Figure 6A and Figure S4I ) and colocalized with CGRP in afferent fibers in laminae I-II ( Figure 6A ). Such Neuron FSTL1 Activates Presynaptic Na + -K + Pump staining patterns were abolished by the dorsal root transaction which causes the degeneration of afferent fibers ( Figure 6A ). Moreover, the a1 subunit mRNA was absent in the dorsal horn neurons ( Figure S4J ), consistent with previous reports (Mata et al., 1991) . These data, together with the coexistence of FSTL1 and the a1 subunit in many small DRG neurons and a number of afferent terminals ( Figures 4C and 6B ), suggest that a1NKA may act in afferent terminals as an autoreceptor for the presynaptic action of FSTL1. The presence of axons containing either the a1 subunit or the FSTL1 ( Figure 6B ) suggests that a1NKA is also accessible to FSTL1 released from nearby axons.
Further spinal cord slice recording showed that the reduction of sEPSC frequency in lamina II neurons induced by exogenous FSTL1 was reversed by 100 mM ouabain ( Figure 6C ). Perfusion with the M3M4 peptide also increased sEPSC frequency ( Figure 6D ) as well as C-fiber stimulation-induced eEPSC amplitude ( Figure 6E ). Thus, afferent synaptic transmission is normally suppressed by endogenously secreted FSTL1 through activation of a1NKA ( Figure 6F ).
FSTL1 Is Required for Maintaining the Normal Threshold of Somatic Sensation
Given that FSTL1-dependent a1NKA activity is required for normal afferent synaptic transmission, we inquired whether a reduction in FSTL1 resulted in sensory modification. Because $90% of FSTL1-containing DRG neurons expressed the Na v 1.8 channel, we made a conditional Fstl1 gene knockout mouse by crossing a mouse with floxed alleles of the Fstl1 gene with a BAC transgenic mouse line expressing Cre recombinase controlled by promoter elements of the Na v 1.8 gene (SNS-Cre) (Agarwal et al., 2004) (Figure 7A and Figure S5A ). In the Fstl1 Figure S5B ), while the expression of the a1 subunit of NKA and other molecules did not change ( Figure 7C ). The number of FSTL1-immunoractive vesicles in small DRG neurons was also reduced in Fstl1 À/À mice ( Figure S5C ).
Whole-cell recording from FSTL1-sensitive lamina II neurons showed that the baseline of sEPSC frequency in Fstl1 À/À mice was elevated, and the K + (15 mM KCl)-induced increase in Figure 7D ). These results were consistent with the suppressive action of FSTL1. We performed in vivo extracellular recording of wide-dynamicrange (WDR) neurons that make synaptic contacts with cutaneous Ad-, C-, and Ab-fibers in spinal laminae III-V. These fibers respond to both thermal and mechanical stimuli (Willis and Coggeshall, 2004) . Stimulation of the receptive field of WDR neurons on the plantar surface of the paw with natural thermal or mechanical stimuli (Urch and Dickenson, 2003) increased the AP firing Neuron FSTL1 Activates Presynaptic Na + -K + Pump rate of WDR neurons in a stimulus-dependent manner (Figure 7E) . The WDR neurons in Fstl1 À/À mice exhibited elevated firing rates compared to Fstl1 +/+ mice, enabling the same stimulus to evoke a higher firing rate ( Figure 7E ). In Fstl1 À/À mice, the firing rate induced by the innocuous stimuli (7.0 ± 1.5 Hz at 38 C and 15.4 ± 1.8 Hz for pressure) was similar to the rate induced by the noxious stimuli (7.9 ± 1.0 Hz at 45 C and 16.3 ± 3.9 Hz for pinch) in Fstl1 +/+ mice. Furthermore, FSTL1
applied to the dorsal spinal cord rescued these phenotypic changes in Fstl1 À/À mice. FSTL1 reduced the firing rate of WDR neurons to the rate found in Fstl1 +/+ mice ( Figure 7E ), thereby showing that hyperexcitability in Fstl1 À/À mice is a direct consequence of FSTL1 loss. As such, FSTL1 is essential for maintaining the normal sensory threshold. We further found that Fstl1 À/À mice exhibited reduced response latencies during radiant heat testing ( Figure 7F ), indicating exaggerated sensitivity to thermal nociceptive stimuli. In the mechanical nociceptive test, the response threshold to von Frey mechanical stimuli applied to the hindpaw was reduced in Fstl1 À/À mice ( Figure 7F ). These behavioral changes were not due to an overall increase in reactivity because Fstl1 À/À mice did not have any apparent changes in open field tests or the accelerating rotarod test ( Figure S5D ). The thermal hypersensitivity in Fstl1 À/À mice was reversed with intrathecal injection of FSTL1, but not FSTL1 E165A ( Figure 7G ). Moreover, after intradermal injection of 0.5% formalin, Fstl1 À/À mice displayed exaggerated responses in both first and second phases of nociceptive reaction ( Figure 7H ). Thus, FSTL1 contributes to the mechanisms for suppressing afferent nociceptive transmission.
DISCUSSION
The present study revealed that the function of FSTL1 was to act as an endogenous high-affinity agonist of a1NKA. Our results further demonstrated that FSTL1 plays a role in regulating synaptic transmission and the threshold of somatic sensation. FSTL1 is secreted from sensory afferent axons and activates presynaptic a1NKA, leading to membrane hyperpolarization and suppression of neurotransmitter release ( Figure 6F ). Finding an endogenous activator of NKA indicates that the Na + -K + pump can be rapidly regulated in vivo by secreted factors in an activitydependent manner. The loss of FSTL1-dependent NKA activation led to enhanced synaptic transmission and sensory hypersensitivity. Therefore, the FSTL1-a1NKA system is essential for the homeostatic regulation of somatic sensation.
Regulation of Synaptic Transmission by Follistatin Gene
Family Members FSTL1 is one of the SPARC proteins in the follistatin gene family (Brekken and Sage, 2000; Hambrock et al., 2004) . However, there is no evidence for functional similarity between FSTL1 and follistatin, which is an activin antagonist and functions during development (Liem et al., 1997; Phillips and de Kretser, 1998) . We found that FSTL1, but not follistatin, suppressed synaptic transmission. Moreover, FSTL1 lacks the conserved functions of other SPARC proteins, which serve as matricellular proteins to mediate cell-matrix interactions (Brekken and Sage, 2000; Hambrock et al., 2004) . We showed that FSTL1 suppressed the synapse by activating a1NKA. Interestingly, agrin (Patthy and Nikolics, 1993) , a member of the follistatin gene family, is broadly expressed in the central nervous system (O'Connor et al., 1994) and enhances neuronal excitation by inhibiting a3NKA (Hilgenberg et al., 2006) . It is possible that agrin and FSTL1 provide bidirectional regulation of synaptic transmission by regulating different isoforms of NKA. Such regulation could be useful for homeostatic modulation of presynaptic neurotransmitter release under different patterns of afferent activities. Whether agrin secretion is activity dependent has yet to be determined. Moreover, both the interaction between NKA and receptors or channels in the presynaptic membrane and the possibility of FSTL1 interaction with various factors in the synaptic cleft may contribute to delicate mechanisms for regulating synaptic activity.
FSTL1 Vesicle Represents a Subtype of Regulated Secretory Vesicles
Both pre-and postembedding immunostaining showed the vesicular localization of FSTL1 and their presynaptic distribution in the afferent terminals. Identification of FSTL1-containing small translucent vesicles provides insight into synaptic vesicle biogenesis (Ferguson et al., 2007; Hannah et al., 1999; Santos et al., 2009) . Our results suggest that most FSTL1 protein is not transported in the synaptoporin-and synapsin-containing vesicles that mediate membrane transport from the TGN to the plasma membrane (Hannah et al., 1999; Okada et al., 1995) . The presence of VAMP2 in FSTL1 vesicles suggests the existence of molecular machinery for exocytosis in these vesicles. Glutamatergic synaptic vesicles are defined by their ability to pack glutamate for secretion, a property conferred by the expression of a VGluT (Daniels et al., 2006; Santos et al., 2009) . Therefore, the vesicles containing both FSTL1 and VGluT2 might form a subset of glutamatergic vesicles in axon terminals. So far, we could not determine the proportion of FSTL1-containing vesicles in the afferent terminals because of the limited sensitivity of immunoelectron microscopy. Based on the findings of the FSTL1 vesicles and the stimulus-induced FSTL1 secretion, which was similar to neuropeptides and glutamate but different from the tenascin-C, we propose that a certain number of FSTL1 vesicles could be stored in the axonal terminals and secreted in response to stimulations.
FSTL1 Is a High-Affinity Activator of NKA The notion that the a1 subunit of NKA serves as a FSTL1 receptor is supported by several lines of evidence. First, both biochemical and radioligand binding data showed high-affinity binding between FSTL1 and the a1 subunit. Second, E314 in M3M4 and T889 in M7M8 of the a1 subunit were identified as critical sites for FSTL1-binding. Third, FSTL1 elevated a1NKA activity and induced membrane hyperpolarization. Fourth, these effects could be attenuated by either inhibiting the a1NKA with 100 mM ouabain or disrupting FSTL1-a1NKA binding with the M3M4 peptide. Finally, the loss of function of FSTL1 E165A is due to its failure to bind to the a1 subunit. Therefore FSTL1, but not FSTL1 E165A , reduced the speed of AP propagation through the NKA-dependent membrane hyperpolarization, resulting in an increased latency of eEPSC. Moreover, the finding that Neuron FSTL1 Activates Presynaptic Na + -K + Pump coexpression of a1 and b1 subunits is required for FSTL1 to produce a potent and stabilized effect supports a role for the b subunit in the delivery and appropriate insertion of the a subunit in the plasma membrane as well as a role in stabilizing the enzyme (Kaplan, 2002) . Thus, FSTL1 is an important endogenously secreted protein that functions as an NKA agonist. It would be interesting to know whether any other a isoformspecific NKA agonists are expressed in various systems. Specific FSTL1-binding sites were identified in M3M4 and M7M8 of the a1 subunit. Blockade of FSTL1 interaction at either EL was sufficient to attenuate FSTL1 action, suggesting that simultaneous FSTL1-binding at both ELs is required. Involvement of M7M8 in FSTL1 action suggests that M7M8 is still accessible to the agonist, even if this EL is proposed to be covered by the extracellular portion of the b subunit (Morth et al., 2007) . The FSTL1-binding sites are distinct from the ouabain-binding sites in the M4 and the M5-M6 hairpin of the a1 subunit (Qiu et al., 2005) . Differences in the binding sites allow ouabain to block FSTL1 action. However, analysis of the structural coordination between FSTL1 and a1NKA is needed to better understand the mechanism of FSTL1 action.
Synaptic Transmission Is Regulated by an Endogenous NKA Agonist
The present study showed that an endogenous agonist is critical for normal activity of the Na + -K + pump at sensory afferent synapses in the dorsal spinal cord. Synaptic transmission was enhanced by either attenuation of endogenous FSTL1 action with ouabain and the M3M4 peptide or genetic deletion of FSTL1. The facilitated synaptic transmission was attributed to a reduction in both the FSTL1-induced tonic suppression of nerve impulse propagation and the activity-induced Ca 2+ -influx, which triggers the release of excitatory neurotransmitters. We postulate that under physiological conditions, presynaptic a1NKA would be tonically activated by spontaneously secreted FSTL1. The elevation of neuronal activity would increase FSTL1 secretion to enhance a1NKA activity, enabling a homeostatic regulation of synaptic transmission ( Figure 6F ). The physiological activity of the Na + -K + pump required an a isoform-specific agonist released from neurons. The fact that relatively small changes in the membrane potential contributed by modulation of NKA activity resulted in marked synaptic effects (Scuri et al., 2007) and sensory processing further underscores the active role of NKA in neuronal function.
FSTL1-a1NKA System Is Essential for Normal Somatic Sensation
The FSTL1 conditional knockout mice showed a reduced threshold of somatic sensation and a hypersensitivity to noxious stimulations. These phenotypic changes were reversed by applying FSTL1, indicating that FSTL1 is a key regulator of sensory transmission. FSTL1 is also required to suppress the sensitization processes of inflammatory pain through both peripheral and central mechanisms because Fstl1 À/À mice displayed an elevated response in both first and second phases of the formalin test. Reduction in FSTL1-dependent homeostatic regulation under pathological conditions, such as regulation resulting from FSTL1 autoantibodies produced by human rheumatoid arthritis (Tanaka et al., 2003) , may contribute to abnormal sensation. Moreover, low a1NKA activity is considered partly responsible for the diabetic neuropathy that causes paresthesias and pain (Krishnan and Kiernan, 2005) . Therefore, we propose that the FSTL1-a1NKA system is fundamental for maintaining the threshold of somatic sensation in the physiological range and dysfunction in this system leads to abnormal sensation such as pain hypersensitivity. 
Preparation of FSTL1 Antibodies
The cDNA encoding 31 amino acids of the C terminus or full-length rat FSTL1 was obtained by RT-PCR and inserted into the pGEX-KG vector (see Supplemental Experimental Procedures). Inducible expression and purification of the recombinant proteins were carried out with the GST gene fusion system. The antibody preparation and specificity tests are described in the Supplemental Experimental Procedures.
Isolation of Vesicles and Immunoblotting
The preparation of vesicles from synaptosomes and immunoblotting are described in the Supplemental Experimental Procedures.
Analysis of Secretion
Levels of secreted FSTL1, CGRP, tenascin-C, SP, and glutamate were measured with immunoblotting, immunoassay, radioimmunoassay, or HPLC methods, respectively (see Supplemental Experimental Procedures).
Immunostaining
Cryostat sections of lumbar (L) 4-5 DRGs and spinal segments were immunostained. Postembedding immunogold labeling and pre-embedding immunoperoxidase staining were performed. To distinguish the immunoperoxidase-labeled vesicles from unlabeled ones, we did not counterstain ultrathin sections with uranyl acetate and lead citrate. For axon immunostaining, the axons from L4-5 dorsal roots were fixed in À20 C methanol and double immunostained. The procedures are provided in the Supplemental Experimental Procedures.
Cell Culture and Transfection COS7 cells were cultured in DMEM containing 10% FBS. The cells were transfected with 1 mg plasmid and 10 ml Lipofectin Reagent (GIBCO) (30 mm dish) in serum-free medium for 6 hr and then in medium containing serum for 2-3 days.
Biochemistry
Neurons cultured from 60 DRGs were preincubated with FSTL1 for 30 min, and then stabilized with membrane-impermeant BS 3 (Pierce) for 60 min (see -ATPase activity (Esmann, 1988) , was measured in the cell lysate (see Supplemental Experimental Procedures). The effect of FSTL1 was also studied with the NKA purified from the rat spinal cord (see Supplemental Experimental Procedures).
Supplemental Experimental Procedures
Equilibrium Binding Assay
The binding of 125 I-FSTL1 to the transfected COS7 cells was measured (see Supplemental Experimental Procedures).
BIAcore Immobilization and Analysis
The binding assay was performed by injecting synthetic peptides corresponding to each EL of the a1 subunit with a series of concentrations over the recombinant FSTL1 immobilized onto the sensor chip (Pharmacia BIAcore) (see Supplemental Experimental Procedures).
Generation of Fstl1-Deficient Mouse
The procedure for generating the conditional Fstl1 knockout mice is given in the Supplemental Experimental Procedures.
Whole-Cell Patch Clamp Recording
Transverse spinal cord slices with an attached dorsal root from adult rats were prepared for blind whole-cell recording (see Supplemental Experimental Procedures). Dorsal root stimulation, which recruits Ad-and C-fibers, was delivered with a suction electrode. Monosynaptic and polysynaptic eEPSCs were studied in the presence of 20 mM bicuculline and 2 mM strychnine (Nakatsuka et al., 2000) . Current-clamp recording was performed in dissociated DRG neurons (see Supplemental Experimental Procedures).
Extracellular Single-Unit Recording of WDR Neurons
The procedure of recording in anesthetized Fstl1 +/+ and Fstl1 À/À male mice is provided in Supplemental Experimental Procedures.
Behavioral Tests
Experiments were carried out following the guidelines of the International Association for the Study of Pain and approved by the Institute of Neuroscience, Chinese Academy of Sciences. The sensitivity of mouse hindpaw to heat or mechanical stimuli was measured. The accelerating rotarod and the open field tests were performed. Formalin (0.5%, 20 ml) was injected into the dorsal surface of the left hindpaw of mice. The licking and lifting time of the injected hindpaw during each 5 min interval for 1 hr after injection was recorded. The procedures are given in Supplemental Experimental Procedures.
Statistical Analysis
Statistical analysis was performed using PRISM (GraphPad Software). Two groups were evaluated by Student's t test. Comparisons among multiple groups were performed by using two-way ANOVA, followed by a two-tailed, unpaired Student's t test for between group comparisons. Differences were considered significant at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, three tables, and Supplemental Experimental Procedures and can be found with this article online at doi:10.1016/j.neuron.2011.01.022.
